AI assistant
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2026
Feb 19, 2026
31542_dirs_2026-02-19_8ef10aed-4dfe-44f9-99cb-7e62aed234fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2026-02-17
Reporting Person: Russo Gregg (Chief HR Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-17 | Common Stock, par value $0.001 per share | M | 687 | — | Acquired | 687 | Direct |
| 2026-02-17 | Common Stock, par value $0.001 per share | F | 211 | — | Disposed | 476 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-17 | Restricted Stock Units | $ | M | 687 | Disposed | Common Stock (687) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2: Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock.
F3: Derivative securities vest in equal tranches, 1/5th each on February 13, 2026, February 13, 2027, February 13, 2028, February 13, 2029, and February 13, 2030.
F4: Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on February 17, 2026.